Article
Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer
7 Oct 2021
Abstract excerpt
According to current guidelines, all women with epithelial ovarian cancer are eligible for genetic testing for BRCA germline pathogenic variants. Unfortunately, not all affected women are tested. We evaluated the acceptability and feasibility for non-genetic healthcare professionals to incorporate germline genetic testing into their daily practice. We developed and implemented a mainstreaming pathway, including a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
